| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Clinical Biochemistry Requirements in the Organization for Economic Cooperation and Development Guidelines — United Kingdom Recommendations
|
Stonard, Michael D.
|
|
1992
|
|
3-2 |
p. 506-508
|
article
|
| 2 |
Clinical Biochemistry Requirements in the Organization for Economic Cooperation and Development Guidelines — United Kingdom Recommendations
|
Stonard, Michael D.
|
|
1992
|
|
3-2 |
p. 506-508
|
article
|
| 3 |
Clinical Pathology for Preclinical Safety Assessment: Current Global Guidelines
|
Hall, Robert L.
|
|
1992
|
|
3-2 |
p. 472-476
|
article
|
| 4 |
Clinical Pathology for Preclinical Safety Assessment: Current Global Guidelines
|
Hall, Robert L.
|
|
1992
|
|
3-2 |
p. 472-476
|
article
|
| 5 |
Clinical Pathology in the National Toxicology Program
|
Thompson, Morrow B.
|
|
1992
|
|
3-2 |
p. 484-489
|
article
|
| 6 |
Clinical Pathology in the National Toxicology Program
|
Thompson, Morrow B.
|
|
1992
|
|
3-2 |
p. 484-489
|
article
|
| 7 |
Clinical Pathology: Preanalytical Variation in Preclinical Safety Assessment Studies-Effect on Predictive Value of Analyte Tests
|
Riley, Julia H.
|
|
1992
|
|
3-2 |
p. 490-500
|
article
|
| 8 |
Clinical Pathology: Preanalytical Variation in Preclinical Safety Assessment Studies-Effect on Predictive Value of Analyte Tests
|
Riley, Julia H.
|
|
1992
|
|
3-2 |
p. 490-500
|
article
|
| 9 |
Clinical Pathology Testing in Preclinical Safety Assessment: Regulatory Concerns
|
Weissinger, Judi
|
|
1992
|
|
3-2 |
p. 509-514
|
article
|
| 10 |
Clinical Pathology Testing in Preclinical Safety Assessment: Regulatory Concerns
|
Weissinger, Judi
|
|
1992
|
|
3-2 |
p. 509-514
|
article
|
| 11 |
Clinical Pathology Testing Recommendations for Nonclinical Toxicity and Safety Studies
|
Weingand, Kurt
|
|
1992
|
|
3-2 |
p. 539-543
|
article
|
| 12 |
Clinical Pathology Testing Recommendations for Nonclinical Toxicity and Safety Studies
|
Weingand, Kurt
|
|
1992
|
|
3-2 |
p. 539-543
|
article
|
| 13 |
Clinical Pathology Testing Regulatory Concerns
|
Kanno, Jun
|
|
1992
|
|
3-2 |
p. 534-537
|
article
|
| 14 |
Clinical Pathology Testing Regulatory Concerns
|
Kanno, Jun
|
|
1992
|
|
3-2 |
p. 534-537
|
article
|
| 15 |
Commentary
|
Weingand, Kurt W.
|
|
1992
|
|
3-2 |
p. 538
|
article
|
| 16 |
Commentary
|
Weingand, Kurt W.
|
|
1992
|
|
3-2 |
p. 538-538
|
article
|
| 17 |
Current Statistical Approaches to Clinical Pathological Data from Toxicological Studies
|
Waner, Trevor
|
|
1992
|
|
3-2 |
p. 477-479
|
article
|
| 18 |
Current Statistical Approaches to Clinical Pathological Data from Toxicological Studies
|
Waner, Trevor
|
|
1992
|
|
3-2 |
p. 477-479
|
article
|
| 19 |
Enzymology in Preclinical Safety Evaluation
|
Davies, Dai T.
|
|
1992
|
|
3-2 |
p. 501-505
|
article
|
| 20 |
Enzymology in Preclinical Safety Evaluation
|
Davies, Dai T.
|
|
1992
|
|
3-2 |
p. 501-505
|
article
|
| 21 |
Interpreting Clinical Laboratory Data in Safety Assessment Studies
|
Carakostas, Michael C.
|
|
1992
|
|
3-2 |
p. 480-483
|
article
|
| 22 |
Interpreting Clinical Laboratory Data in Safety Assessment Studies
|
Carakostas, Michael C.
|
|
1992
|
|
3-2 |
p. 480-483
|
article
|
| 23 |
Introduction
|
Stitzel, Katherine
|
|
1992
|
|
3-2 |
p. 469
|
article
|
| 24 |
Introduction
|
Stitzel, Katherine
|
|
1992
|
|
3-2 |
p. 469-469
|
article
|
| 25 |
Present Status of Animal Clinical Pathology Examinations in the Japanese Pharmaceutical Manufacturers Association
|
Matsuzawa, Toshiaki
|
|
1992
|
|
3-2 |
p. 528-533
|
article
|
| 26 |
Present Status of Animal Clinical Pathology Examinations in the Japanese Pharmaceutical Manufacturers Association
|
Matsuzawa, Toshiaki
|
|
1992
|
|
3-2 |
p. 528-533
|
article
|
| 27 |
Regulatory Concerns in the Current Practices of Clinical Pathology
|
Cavagnaro, Joy A.
|
|
1992
|
|
3-2 |
p. 519-522
|
article
|
| 28 |
Regulatory Concerns in the Current Practices of Clinical Pathology
|
Cavagnaro, Joy A.
|
|
1992
|
|
3-2 |
p. 519-522
|
article
|
| 29 |
Regulatory Concerns of the United States Environmental Protection Agency
|
Fenner-Crisp, Penelope
|
|
1992
|
|
3-2 |
p. 523-525
|
article
|
| 30 |
Regulatory Concerns of the United States Environmental Protection Agency
|
Fenner-Crisp, Penelope
|
|
1992
|
|
3-2 |
p. 523-525
|
article
|
| 31 |
The Value of Clinical Chemistry Data in Animal Screening Studies for Safety Evaluation
|
Irausquin, Hiltje
|
|
1992
|
|
3-2 |
p. 515-518
|
article
|
| 32 |
The Value of Clinical Chemistry Data in Animal Screening Studies for Safety Evaluation
|
Irausquin, Hiltje
|
|
1992
|
|
3-2 |
p. 515-518
|
article
|
| 33 |
Thoughts on the Proper Use and Interpretation of Clinical Pathology Data in Preclinical Safety Testing: A Canadian Perspective
|
Mueller, Rudolf W.
|
|
1992
|
|
3-2 |
p. 526-527
|
article
|
| 34 |
Thoughts on the Proper Use and Interpretation of Clinical Pathology Data in Preclinical Safety Testing: A Canadian Perspective
|
Mueller, Rudolf W.
|
|
1992
|
|
3-2 |
p. 526-527
|
article
|
Journal description